Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Yuanjia Biotechnology is a China-based healthcare company that appears to have focused on introducing and commercializing ex-China medical and pharmaceutical products in the Chinese market, rather than building a broad in-house therapeutic pipeline. Publicly available descriptions characterize the company as an international pharmaceutical company whose mission was to bring medicinal products already approved in the EU or US into China. The clearest disclosed program is its commercialization work around VagiVital, a non-hormonal product for vaginal atrophy and vaginal dryness, supported through local distribution, market development, and registration-related activities in China. Chinese registry sources indicate the company was founded in 2019 in Shijiazhuang, Hebei. However, registry data available online also indicates the company is no longer active and has been listed as revoked/deregistered rather than operating as an ongoing standalone biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Yuanjia Biotechnology.